Cross Country Healthcare Files 8-K on Shareholder Nominations
Ticker: CCRN · Form: 8-K · Filed: Sep 30, 2025 · CIK: 1141103
| Field | Detail |
|---|---|
| Company | Cross Country Healthcare INC (CCRN) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-nomination, filing
Related Tickers: CCRH
TL;DR
CCRH filed an 8-K on 9/30 for 9/25 events, including shareholder nominations. Watch for governance changes.
AI Summary
Cross Country Healthcare, Inc. filed an 8-K on September 30, 2025, reporting on shareholder nominations and other events as of September 25, 2025. The filing pertains to their operations as a healthcare staffing services company incorporated in Delaware.
Why It Matters
This filing indicates potential changes or discussions related to the company's board or governance structure, which could impact strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural and reports on standard corporate events without immediate financial implications.
Key Players & Entities
- Cross Country Healthcare, Inc. (company) — Registrant
- September 25, 2025 (date) — Date of earliest event reported
- September 30, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific shareholder nominations were reported in this 8-K filing?
The filing indicates that shareholder nominations were an item of business reported, but the specific details of these nominations are not provided in the excerpt.
What is the primary business of Cross Country Healthcare, Inc.?
Cross Country Healthcare, Inc. operates in the healthcare staffing services industry, as indicated by its SIC code [7363].
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 25, 2025.
What is the principal executive office address for Cross Country Healthcare, Inc.?
The principal executive office is located at 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487.
What is the fiscal year end for Cross Country Healthcare, Inc.?
The fiscal year end for Cross Country Healthcare, Inc. is December 31.
Filing Stats: 914 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2025-09-30 16:39:11
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share CCRN The Nasdaq Stock Market
Filing Documents
- ccrn-20250925.htm (8-K) — 32KB
- ccrn-20250925_g1.jpg (GRAPHIC) — 46KB
- 0001628280-25-043262.txt ( ) — 264KB
- ccrn-20250925.xsd (EX-101.SCH) — 2KB
- ccrn-20250925_lab.xml (EX-101.LAB) — 21KB
- ccrn-20250925_pre.xml (EX-101.PRE) — 12KB
- ccrn-20250925_htm.xml (XML) — 3KB
08 Shareholder Director Nominations
Item 5.08 Shareholder Director Nominations. To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.
01 Other Events
Item 8.01 Other Events. O n September 25, 2025, the Board of Directors (the "Board") of Cross Country Healthcare, Inc. (the "Company") determined that the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting") will be held on December 9, 2025, which is more than 30 days after the anniversary of the Company's 2024 Annual Meeting of Stockholders. The Annual Meeting does not relate to the pending merger transaction with Aya Healthcare, Inc. (the "Aya Merger") and will only take place in the event that the Aya Merger is not completed prior to the Annual Meeting. The Company continues to expect that the Aya Merger will be completed in the fourth quarter of 2025. Should the Aya Merger be completed before the Annual Meeting, the Company will be a wholly owned subsidiary of Aya Healthcare, Inc. and, accordingly, such Annual Meeting will not occur and any director candidates or stockholder proposals submitted will not be considered by the Company ' s stockholders. The time and website address for the virtual-only Annual Meeting will be set forth in the Company's proxy statement for the Annual Meeting, which will be made available to stockholders prior to or on October 30, 2025. Pursuant to Rule 14a-5(f) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company is hereby providing notice of the below revised deadlines for qualified stockholder proposals and stockholder nominations by means of this Current Report on Form 8-K. In order for a stockholder proposal for the Annual Meeting to be eligible for inclusion in the Company's proxy statement pursuant to Rule 14a-8 of the Exchange Act, the Company must have received the proposal and supporting statements at its principal executive office no later than the close of business on October 10, 2025, which the Board has determined is a reasonable time before the Company begins to print and send its proxy materials. All stockholder proposals and/or notices should be sent to the Compa